- 专利标题： Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
-
申请号： US16098260申请日： 2017-05-04
-
公开(公告)号： US10544099B2公开(公告)日： 2020-01-28
- 发明人: Emily Charlotte Cherney , Liping Zhang , David K. Williams , James Aaron Balog
- 申请人： BRISTOL-MYERS SQUIBB COMPANY
- 申请人地址： US NJ Princeton
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： US NJ Princeton
- 代理机构： BakerHostetler
- 国际申请： PCT/US2017/031040 WO 20170504
- 国际公布： WO2017/192840 WO 20171109
- 主分类号： C07D215/18
- IPC分类号： C07D215/18 ; C07D215/233 ; C07D401/04 ; A61P35/00 ; A61K31/47 ; A61K31/4709 ; A61K45/06
摘要：
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
公开/授权文献
信息查询
